Liberty Biopharma (CVE:LTY) Stock Price Passes Above Fifty Day Moving Average – Here’s Why

Liberty Biopharma Inc (CVE:LTY)’s stock price passed above its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of C$2.00 and traded as high as C$2.00. Liberty Biopharma shares last traded at C$2.00, with a volume of 700 shares traded.

Liberty Biopharma Trading Up ∞

The company has a current ratio of 0.12, a quick ratio of 0.12 and a debt-to-equity ratio of 8.19. The business has a 50 day simple moving average of C$2.00 and a two-hundred day simple moving average of C$2.00. The stock has a market cap of C$21.54 million and a price-to-earnings ratio of -12.66.

Liberty Biopharma Company Profile

Liberty Biopharma Inc, a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of an automated bioprocessing and cell isolation technology. Its technology is used in the isolation of regenerative cells from human adipose tissues for use in research, cosmetic and aesthetic medicine, burn management, wound management and non-healing wounds, cardiovascular and heart diseases, peripheral arterial disease, critical limb ischemia or diabetic leg, and hepatic disease and kidney disease.